| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0007 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.091 | 0.001 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.19 | 0.001 |